Related Experiment Video
Updated: Aug 12, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story
1Department of Bacteriology, University of Bristol, England.
Abstract:
The period since the introduction of beta-lactam antibiotics for therapeutic purposes has been characterized by a number of phases during which the incidence of resistant bacteria causing clinical infections has been high. Initially, penicillin-resistant staphylococci were the problem; more recently, it has been the resistant gram-negative bacteria, including anaerobes, that have given cause for concern. Thus novel beta-lactam antibiotics with activity against the resistant organisms have been developed. For the staphylococci methicillin, oxacillin, and cloxacillin were introduced, and for gram-negative species, cefuroxime and cefoxitin. Cefoxitin is particularly useful for treatment of infections due to anaerobes and ampicillin-resistant isolates of Escherichia coli. In all cases the best way to achieve efficacy against resistant bacteria seems to have been to design antibiotics that are insensitive to hydrolysis by beta-lactamases.
Related Concept Videos
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance

